A combination flu and Covid-19 vaccine has passed the test in animals and can now move on to trials in humans. — AFP
American biotech firm Novavax said on May 10 (2021) that it had positive results from preclinical studies of a shot combining its influenza and Covid-19 vaccine candidates.
The study, now on a preprint server and awaiting peer review, showed that the shot produced strong levels of antibodies against both diseases in ferrets and hamsters.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
